Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin and EPA for Neoatherosclerosis (LINK-IT)
NCT03192579Phase 4Completed
- Sponsor
- Kobe University
- Start
- Jul 2013
- Primary completion
- Jun 2017
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of eicosapentaenoic acid, rosuvastatin in neoatherosclerosis, sponsored by Kobe University. Started Jul 2013; status: completed.
02
Drugs
eicosapentaenoic acidrosuvastatin
03
Conditions
neoatherosclerosis
Beyond the preview
Go deeper on NCT03192579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03192579.